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Abstract
Predicting candidate genes using gene expression profiles and unbiased protein-protein interactions (PPI) contributes a lot
in deciphering the pathogenesis of complex diseases. Recent studies showed that there are significant disparities in network
topological features between non-disease and disease genes in protein-protein interaction settings. Integrated methods
could consider their characteristics comprehensively in a biological network. In this study, we introduce a novel
computational method, based on combined network topological features, to construct a combined classifier and then use it
to predict candidate genes for coronary artery diseases (CAD). As a result, 276 novel candidate genes were predicted and
were found to share similar functions to known disease genes. The majority of the candidate genes were cross-validated by
other three methods. Our method will be useful in the search for candidate genes of other diseases.
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Introduction
Many complex diseases like coronary artery disease result from
a complex interplay of multiple genes. A great challenging of
biomedical research is to identify candidate genes, which will
further help elucidate their roles in the pathogenesis of complex
diseases. Recent accumulation of reliable molecular interaction
data has boosted progress in the discovery of novel susceptibility
genes and fueled expectations about opportunities of computa-
tional approaches for distinguishing disease-related genes from
non-disease ones. Recent studies on the prediction of candidate
genes based on PPI networks alone or in addition to gene
expression profiles [1,2,3] could return potential candidate genes
and facilitate a better understanding of the role of their topological
features in the prediction of susceptibility genes so far, but all have
investigated only one or two network topological features. Previous
discoveries [4,5,6,7,8] demonstrated that direct interaction
partners of a protein are likely to share similar functions with it,
and causative genes of some complex disease tends to reside in the
same network communities such as biological modules, protein
complexes, pathways or subnetworks of a given biological network.
Some further graph-theoretical analyses of molecular interaction
networks [8,9,10,11] have succeeded in identifying biological
network modules and deciphering the association between genes
and diseases. To sum up, a unified underlying hypothesis states
that genes sharing similar network topological features with known
disease genes may result in the same phenotypes. Support Vector
Machine (SVM), assumed as ‘a machine-learning algorithm’ based
on the Statistical Learning Theory (SLT), is generally introduced
into tackling classification problems. SVMs could have good
classification effects and performances with a few learning samples
[12]. SVMs make predictions and give final classification decisions
through learning from existing knowledge automatically [13].
Recently, SVMs have become very popular in the applications of
a wide variety of biological questions or topics
[13,14,15,16,17,18], including gene classification, functional pre-
diction and cancer tissue classifications. To a certain extent,
identifying candidate genes for a complex disease could be
regarded as a problem of distinguishing disease genes from non-
disease genes, which is one of the right problems that SVMs work
on. Apart from that, with the accumulation of human protein-
protein interaction networks, it is also necessary to introduce novel
approaches to find out effective network topological features for
gene classifications, and then further aid in the prediction of
candidate disease genes.
According to the hypothesis that genes sharing similar network
topological features in biological network settings might result in
the same or similar phenotypes, we introduced a method, termed
eCTFMing, to identify effective combined network topological
features and then utilize them into the candidate gene predication.
In this article, we firstly identified whether the primary features are
effective or not in classification of disease- and non-disease genes,
and then screened out effective features from primary features.
Finally, a set of optima combined features was constructed to carry
out our final prediction. After that, functional coherence between
candidate and known disease genes was examined to verify
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performance, we compared eCTFMining with three other
methods.
Materials and Methods
In this article, we introduced a method, called eCTFMing, to
identify candidate disease genes by analyzing network topological
features of genes in a PPI network. Figure 1 shows the detailed
steps of this method(see in Figure 1).
Data Sources and Preprocessing
The interactions of the Human Protein Reference Database
(HPRD, http://www.hprd.org/) are all manually extracted from
literatures by expert biologists who read, interpret and analyze
the published data. In order to validate whether our approach
relies upon the PPI data, we used an unbiased data sources from
Sebastian Kohler et al. [19] to predict candidate genes. Sebastian
Kohler et al. [19] constructed a PPI network which had 258314
interactions between 13725 genes. This PPI network contains five
PPI datasets from Homo Sapiens, Mus musculus, Drosophila
melanogaster, Caenorhabditis elegans, and Saccharomyces cerevisiae and
these datasets comprise interactions extracted from HPRD,
BIND and BioGrid and additional interactions from IntACT,
DIP and STRING.
Gene expression profiles of CAD were downloaded from the
NCBI Gene Expression Omnibus (GEO, http://www.ncbi.nlm.
nih.gov/geo/) database with the accession numbers being
Figure 1. Flowchart of the eCTFMing method. This flowchart contains three mainly steps: (a) Screening of optima combined feature, (b)
prediction strategies and (c) validation followed throughout this study.
doi:10.1371/journal.pone.0039542.g001
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step, differential expression analysis was performed to screen out
differentially-expressed genes within each profile. A global
median normalization was carried out. The differentially
expressed genes were identified by t-test and a p-value cutoff
of 0.05 was selected to find differentially expressed genes. An
intersection manipulation was carried out to get differentially-
expressed genes in common in these three profiles. It should be
noted that the chromosomal locations for the differentially-
expressed genes were downloaded from the Ensemble database
(http://www.ensembl.org/index.html). In addition, one hundred
and thirty eight known disease genes and one hundred and sixty
eight disease loci for this disease were acquired from the Online
Mendelian Inheritance in Man database (OMIM, http://www.
ncbi.nlm.nih.gov/sites/entrez?db=OMIM).
Construction of Positive, Negative and Test Sets
Positive genes were defined as CAD disease genes collected
from the OMIM online database and literature mining. Negative
genes consisted of all the remaining genes in the human PPI
network by excluding positive genes and differentially-expressed
genes. The test gene set is the intersection between the
differentially-expressed genes and those genes located within the
disease loci.
Selection of Network Topological Features
For all these three gene sets, we defined six commonly-used
measurements for each gene, gi, to evaluate its network topological
features in the PPI network.
N Degree (D): in the network, the degree of gene gi is equal to the
number of its adjacent links.
N Neighbor count of disease genes (N): N is the number of
neighboring disease genes among all the neighboring genes of
gene gi.
N Ratio of disease genes in neighbor (R): R is the ratio of the
count of neighboring disease genes to the count of all neighbor
genes.
N Betweenness centrality (B): the betweenness centrality of gene
gi is the count of shortest paths between other nodes that run
through the node of interest.
N Clustering coefficient (C): C is the ratio of the number of edges
between a vertex’s neighbors to the total possible number of
edges between the vertex’s neighbors.
N Mean shortest path length to disease gene (M): A shortest path
between two nodes corresponds to the minimum number of
edges that have to be traversed in a network to get from one
node to the other. In this study, we calculated the average
length of shortest paths from gene gi to all the disease genes.
According to these network topological measurements, we got
a vector V of topological features, labeled as (D, N, R, B, C, M),
and then tested whether there was a significant disparity between
positive and negative gene sets or not. In this step, a Wilcoxon
rank sum test analysis for each measurement was performed
between positive and negative sets and the corresponding
significance threshold (p value) was set to 0.05.
Identification of Effective Topological Features
A ten-fold cross-validation test was used to evaluate the
classification performance and then screen out optima training
set for SVM classifications. Six specific topological features were
the primary input features for training six support vector machines
with each one performing for 1,000 randomizations. The pre-
diction power was evaluated by precision, true positive rate (TPR)
and false positive rate (FPR). These three indexes were jointly used
to pre-screen these topological features.
Combination of Effective Features and Identification of
Optima Combined Features
It should be noted that at this step all possible combinations
were considered. If we have n features in the topological feature
vector V, there will be 2
n combinations in total. Then we
combined the effective topological features, retrained the SVMs
using each combined feature out of 2
n21 combinations and
performed the SVM classification predictions for 1,000 randomi-
zations. After that, the classification performance was evaluated by
precision, TPR and FPR. The best combinations were chosen as
optima combined features.
Prediction of Candidate Genes
The optima combined features were used to pick out candidate
genes of CAD from the test gene set. This process was performed
repeatedly for 10,000 randomizations. With each randomization,
we tested whether each gene could be classified to be a disease
gene. If so, this gene was finally assumed as a candidate gene in
our result.
Analysis of Functional Coherence
We applied BiNGO [20], a Cytoscape [21] plug-in, to assess
which Gene Ontology (GO, http://www.geneontology.org/)
terms were significantly overrepresented in a set of known disease
genes. Benjamini and Hochberg multiple testing corrections were
used to adjust the raw P-values with the significance threshold
being 0.05. Meanwhile, GO function annotations were acquired
for candidate genes. And then, we tested whether candidate genes
shared the same functions with known disease genes to validate the
associations of candidate genes with this disease.
The Web-based Gene Set Analysis Toolkit [22] (WebGestalt) is
a suite of tools for functional enrichment analysis in various
biological contexts. Here, we used it to compare candidate and
disease gene lists with genes in KEGG pathway contexts
respectively to identify significant pathways which candidate and
disease genes located in. A significant level of 0.01 was selected as
the cutoff for selecting significantly enriched pathway categories.
Results
Selection of Network Topological Features
According to results in Table 1 and Figure 2, we found that
these widely-used topological features did have more or less
contributions individually for classifications of positive and
negative genes. From the probability distribution in Figure 2a,
together with median results in Table 1, most CAD positive
genes were linked to more interacting neighbors than negative
ones in the network. To be more exact, a majority of negative
genes had less than eight links to other nodes. In contrast, there
were visible differences in their neighboring links between CAD
positive and negative genes when the values went higher than 8.
Noticeably, most positive genes were connected to more than 18
neighbors, indicating that CAD positive genes, to some degree,
are very likely to be hub node members in the network, which is
coincident with previous study [23]. In addition, nearly 87.3% of
negative genes had no direct interactions with known disease
genes, while 32% of positive genes had at least one link to known
disease genes. As for the betweenness centrality, positive genes
were with higher connectivity to create short path lengths
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These CAD positive genes will naturally experience much higher
visits because of this added connectivity (Figure 2b). When it
comes to the clustering coefficient, more than 50% of the
negative genes had a clustering coefficient of zero, which
indicated that the majority of CAD negative genes were likely
to be isolated nodes (Figure 2c). Additionally, disease genes had
slightly shorter path lengths than non-disease genes, and shortest
path lengths were ranging from two to four between disease
genes (Figure 2d). Therefore, it seems to be possible to utilize
these network topological features to train Support Vector
Machines in distinguishing CAD disease genes from non-disease
genes through network topological analysis.
Confirmation of Effective Topological Features
As for each of the topological features, a corresponding SVM
classifier was trained and its precision, true positive rate (TPR) and
false positive rate (FPR) were evaluated to confirm whether this
feature was effective in gene classification. One criterion was that
each of the resulting features we chose should have relative higher
values of classification precision and TPR but lower value of
classification FPR. In figure 3, we found the classification
performance of the betweenness centrality measurement was of
lower values of precision and TPR but higher value of FPR,
indicating that betweenness could not be selected as an effective
feature in further classification. And the classifiers of D, N and M
features had higher precision, respectively. We also found that
Table 1. Summary of Significance analysis and median values of the topological features for the positive genes and negative
genes.
Mean p value
Positive Set Negative Set
Degree 6.9805 16.735 5.11E215
Neighbor number of disease gene 0.1916 1.0427 0
Ratio of disease gene in neighbor 0.0263 0.1115 0
Betweenness centrality 2.41E+04 8.31E+04 1.40E213
Clustering coefficient 0.1048 0.0882 7.61E205
Mean shortest path length to disease gene 3.7379 3.2778 2.04E219
doi:10.1371/journal.pone.0039542.t001
Figure 2. Probability distributions of the ‘Degree’, ‘Betweenness Centrality’, ‘Clustering Coefficient’ and ‘Mean Shortest Path
Length’ topological features for positive and negative gene sets.
doi:10.1371/journal.pone.0039542.g002
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the FPR of B and C features were both much higher than the
others. Afterwards, according to the threshold of precision, TPR
and FPR, five network topological features (C, D, M, N, and R)
were finally retained and confirmed as effective features for
distinguishing CAD disease genes from non-disease genes.
Combining Topological Features and Screening Optima
Combined Features by SVM
We retrained 31 (2
521) SVMs for gene classification with each
of the corresponding combinations of five effective topological
features as feature inputs. Then their classification performances
were evaluated according to values of precision, TPR and FPR
(see in Figure 4). From the results, the combined features of N, R,
C and M could effectively distinguish disease from non-disease
genes. We defined these combined features as optima combined
features.
Disease Genes Prediction
During the SVMs trainings and predictions, we randomly
selected negative genes with an identical number of positive genes
from the negative gene set as the size of negative gene set was
much larger than positive one. For fear of the possible selection
bias, this step of disease gene prediction was performed for 10,000
times to get CAD candidate genes using the optima combined
features, while the negative gene inputs were different between
every two manipulations. After 10,000 predictions, the intersection
of each prediction was defined as our final prediction, and 276
candidate genes were finally returned.
Analysis of Functional Coherence
Functional coherence between candidate and known disease
genes was examined to verify associations of candidate genes with
the disease. In this step, we performed function and pathway
enrichment analyses for candidate and disease genes, respectively.
BiNGO, a Cytoscape plugin to assess overrepresentation of
Gene Ontology categories in Biological Networks, was used to
map the predominant functional themes of the tested gene set on
the GO hierarchy, and take advantage of Cytoscape’s versatile
visualization environment to produce an intuitive and customiz-
able visual representation of the results. Genes associated with the
same disease phenotype were found to share common cellular and
functional characteristics, as annotated in the Gene Ontology (See
in Figure S1 and Table S1). We found that a majority of CAD
candidate genes that had similar network topological features
tended to have a significantly functional relatedness to known
disease genes in following categories such as protein binding, receptor
binding, molecular transducer activity, signal transducer activity, receptor
activity, oxidoreductase activity, hydroxymethylglutaryl-CoA reductase
(NADPH) activity and so on. Moreover, a partial of CAD candidate
and known disease genes were annotated on the GO terms of
‘auxiliary transport protein activity’, ‘carbohydrate binding’ and ‘lipid
binding’. Genes with similar phenotypes might share similar
functions; therefore we compared the 276 candidate genes with
the cardiovascular GO annotation initiative genes (Table S1). We
found that 216 of the candidate genes were in the Cardiovascular
GO Annotation list of genes known to be associated with
cardiovascular processes. For example, one gene (CD55) was
found to influence monocyte cholesterol homeostasis and partic-
ipate in the development of CAD [24].
Figure 3. Performances of six topological features by SVM. A: Precision; B: TPR; C: FPR. (D) - Degree; (N) - Neighbor number of disease gene;
(R) - Ratio of disease gene in neighbor; (B) - Betweenness centrality; (C) - Clustering coefficient; (M) - Mean shortest path length to disease gene.
doi:10.1371/journal.pone.0039542.g003
Figure 4. Performances of combined topological features by SVMs. D - Degree; N - Neighbor number of disease gene; R - Ratio of disease
gene in neighbor; C - Clustering coefficient; M - Mean shortest path length to disease gene. The character labels represented the combined
topological features, respectively.
doi:10.1371/journal.pone.0039542.g004
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functional enrichment analysis in various biological contexts. It
was used to evaluate the overlaps of candidate and disease gene
lists with genes in KEGG pathway contexts respectively and then
significant pathways which candidate and disease genes located in
were identified. We found many candidate genes participated in
specific KEGG pathways where known disease genes were over-
represented and these two gene sets shared 60 (nearly 25%)
common KEGG pathways such as cytokine-cytokine receptor interaction,
Regulation of actin cytoskeleton, Focal adhesion, MAPK signaling pathway,
Adipocytokine receptor signaling pathway, VEGF signaling pathway, Type I
diabetes mellitus, hematopoietic cell lineage, and complement and coagulation
cascades and so on (Table S2).
One interesting result we found was that known and candidate
disease genes were over-represented in the KEGG pathway of
cytokine-cytokine receptor interaction (Figure 5), which might
suggest involvement of inflammation in the CAD process. In this
pathway, candidate genes like LTBR, IFNGR1, SF14 and IL1R2
tended to have direct interactions with known disease genes. Some
of our results had been cross-validated by previous studies. It is
known that the cytokine network is a complex and dynamic system
composed of numerous biological responses in human body.
Cytokines and their interaction with the coagulation system play
important roles, especially [25] in the maintenance of the
thrombo-hemorrhagic balance in vivo in human subjects. Martins
et al. [26] declared that cytokine profiles may have a role in
differentiating patients with CAD with myocardial infarction from
those with chest pain due to other disorders and in deciphering the
role of inflammation in the pathogenesis of CAD. Tiroch et al. [27]
argued that gene expression analysis in atherectomy specimens
derived from restenotic coronary lesions indicated activation of
Interferon gamma signaling in neointimal smooth muscle cells,
which, in some way, verified the role of the candidate gene, the
Interferon gamma (IFNG) gene, in the pathogenesis of CAD. Kim
et al. [28] further suggested IFNG gene may be one of the factors
determining the extent of CAD in the Korean population. Also,
ghrelin encoded by the GHR gene, a novel endogenous ligand for
the growth hormone secretagogue receptor, was considered [29] to
exert a protective effect against atherosclerosis. The LEPR gene,
a member of the family of cytokine receptors type I, encodes the
protein of leptin, which is also an independent risk factor [30,31]
for CAD. Because thrombus formation is a major cause of acute
coronary events and leptin was shown previously to facilitate ADP-
induced platelet aggregation. Leptin-induced platelet activity
required activation of a signaling cascade that included the long
form of the leptin receptor, three kinases of JAK2, PI3K and
PKB/Akt, IRS-1, and PDE3A. In addition, smooth muscle cell
(SMC) proliferation in atherosclerosis was found [32] to mediate
through the interaction of growth factors like platelet-derived
growth factor-RB (PDGF-RB) and insulin-like growth factor-1
(IGF-1) and their receptors (R).
Another interesting findings was that known and candidate
disease genes were over-represented in the KEGG pathway of
hematopoietic cell lineage (Figure 6), which might also suggest
Figure 5. The detailed interaction information of known and candidate disease genes in the KEGG pathway of cytokine-cytokine
receptor interaction. Blue nodes represent candidate disease genes, and the yellow ones represent known disease genes.
doi:10.1371/journal.pone.0039542.g005
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pathway, IL2RA, IL3, CD9, CD10, CD25 and CD117 appeared
to interact with known disease genes directly, while some of our
results were verified by previous CAD-related studies. Tabata et al.
[33] declared that engagement of one candidate gene, namely the
cell-adhesion CD44 gene, with low molecular weight hyaluronan
was centrally involved in the inflammatory pathogenesis of
athelosclerotic plaques through migration of monocytes and
foamed macrophage differentiation. Hagg et al. [34] showed that
pro-inflammatory cytokines could affect the expression of CD44
and also examined the role of elevated CD44 expression levels in
human macrophages. To be more exact, an IL-6-CD44 feedback
loop was found in macrophages and this positive feedback loop
may be the cause of aggravating atherosclerosis development.
Figure 6. The detailed interaction information of known and candidate disease genes in the KEGG pathway of hematopoietic cell
lineage. Blue nodes represent candidate disease genes, and the yellow ones represent known disease genes.
doi:10.1371/journal.pone.0039542.g006
Figure 7. The detailed interaction information of known and candidate disease genes in the KEGG pathway of complement and
coagulation cascades. Blue nodes represent candidate disease genes, and the yellow ones represent known disease genes.
doi:10.1371/journal.pone.0039542.g007
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clustering within microdomains experienced noticeable effects in
response to in vivo lipopolysaccharide (LPS) and/or atherogenic
lipoprotein activation. Moreover, they observed more evidences of
increased DRM-association of the GPI-anchored proteins CD14,
CD55, CD64, the scavenger receptors CD36, CD91 and CD163,
the integrin CD11a, and complement receptor 3 complex
CD11b/CD18 from patients with CAD.
In figure 7, we assumed the KEGG pathway of complement
and coagulation cascades might be CAD risk related. Candidate
and known disease genes in this pathway, appearing to be altered
in patients with CAD, acted an important role [35] in the
complement cascade and the innate immunity as well as in the
regulation of proteolytic cascade involved in inflammatory and
coagulation processes. Apart from that, the increased levels or
genetic mutations in the F2 receptor (F2R) involved in coagulation
may play a role in the pathogenesis of coronary artery disease. By
virtue of its strong correlation to plasma TNF-alpha, F2R may be
an important mediator [36] of the effects of inflammation on the
vessel wall, and this study further provided promising strategies of
blocking F2R to the treatment of human atherosclerosis. Another
study demonstrated that in men F2R genetic variants tended to
influence the risk of the occurrence of myocardial infarction
mainly through an interaction with IL6 serum levels. Changes in
plasminogen activator inhibitor 1 and tissue-type plasminogen
activator (PLAT gene) [37] were detected during exercise in
patients with coronary artery disease. Karlsson et al. [38] argued
that there might be a role of plasma and tissue-type plasminogen
activator in coronary atherosclerosis, suggesting that treatment
with recombinant tissue-type plasminogen activator (PLAT), in
unstable coronary artery disease in men reduced myocardial
ischemia.
Comparison with other Methods
Similar to our method, Prioritizer and PandS methods could
be used to rank genes related to a specific disorder with the
assumption that disease genes in a specific disorder are usually
functionally related. Also, on the basis of the assumption that
phenotypically similar diseases are caused by functionally related
genes, CIPHER [6] could integrate human protein–protein
interactions, disease phenotype similarities, and known gene–
phenotype associations effectively, assuming as a global network-
based inference approach for human disease gene identification.
While, Prioritizer [39] ranks genes based on their functional
interactions with genes in different susceptibility loci. As for
PandS(PROSPECTR and SUSPECTS combined) [40], PRO-
SPECTS differentiates between disease and non-disease genes
using sequence-based features; SUSPECTS scores candidate
genes using the PROSPECTR algorithm and also assess the
similarity between their annotations and those of known disease
genes. To validate the results with those obtained by our method,
the Prioritizer, PandS and CIPHER methods were introduced to
explore CAD candidate genes through the genome-wide scan of
CAD susceptibility loci. From the results, we can safely draw
a conclusion that our candidate CAD genes could be cross-
validated by these well-known disease gene identification
methods and show close associations in shared disease risk
pathways or GO functional categories with known CAD disease
genes (see in Table S1).
Discussion
Coronary artery disease, as one of complex diseases, is
assumed to be caused by the combined effects of multiple
disease genes. We found that the eCTFMining method could
take into account of different network topological features of
genes in the biological network to characterize their possible
functional relationships with known disease genes and further aid
in the disease gene identification. In our research, CAD-related
genes are likely to have the following characteristics: i) they tend
to be hubs in the network, often with more links to other genes
than non-disease genes; ii) these genes follow the rule of ‘guilty
by association’, and if there are more disease-related interacting
neighbors for a gene, this gene is more likely to be a candidate;
iii) the neighborhood of one disease gene is well connected in the
network namely that CAD disease genes have much higher
clustering coefficient values than non-disease genes; and iv)
disease genes are likely to locate in small-world subnetworks as
the mean shortest path length between disease genes is generally
less than 4 (see in Figure S2).
It must be noted that several human processes like the cytokine-
cytokine receptor interaction pathway, the hematopoietic cell
lineage pathway, the complement and coagulation cascades
pathway show significant associations with coronary artery disease,
which also suggest involvement of inflammation in the disease
development. Thus, there might be common mechanisms between
the inflammatory pathogenesis and coronary artery disease. Apart
from that, some attentions should be paid to those pathways as
they mainly consist of CAD candidate genes and known disease
genes. Here, we declare that studies on CAD disease-related
pathways might provide insights into possibly promising drug
target discovery.
Different from other methods based on single topological
feature, our method takes advantage of all the commonly-used
network topological features and then searches the optima feature
combinations for CAD disease gene identification. Our method
has returned affluent results in CAD disease gene prediction and
a majority of them have been cross-validated by another method
or two. Few candidate genes that are not verified by current
knowledge systems would help researchers to create new
hypothesis for experiments. However, our method relies partly
on the confidence in, and quality of, PPI or known disease gene
datasets. To sum up, with further improvement of protein-protein
interaction networks and disease genes databases, the performance
of our method could be more effective and dependable.
Supporting Information
Figure S1 The GO function annotation of known disease
genes and candidate disease genes. Dark yellow circular
nodes are more significantly overrepresented by known disease
genes. White nodes are not significantly overrepresented; they are
included to show the yellow nodes in the context of the GO
hierarchy. The area of a node is proportional to the number of
genes in the test set annotated to the corresponding GO category.
The square nodes are significantly overrepresented by known and
candidate disease genes.
(TIF)
Figure S2 Distribution of the topological features of
positive/negative genes and candidate genes.
(TIF)
Table S1 List of 276 candidate disease genes.
(DOC)
Table S2 Pathway list of enrichment by known and
candidate disease genes.
(DOC)
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